Breaking Research News from Breastcancer.org

Ibrance Offers Benefits as Second-Line Treatment for Advanced-Stage Disease

June 3, 2015

A study has found that Ibrance combined with the hormonal therapy Faslodex (chemical name: fulvestrant) more than doubled progression-free survival compared to Faslodex alone in postmenopausal women diagnosed with hormone-receptor-positive, HER2-negative advanced-stage breast cancer that had grown while being treated with first-line hormonal therapy

All Bisphophonates Reduce Recurrence Risk the Same Amount
June 9, 2015
All bisphosphonates seem to offer the same recurrence risk reduction benefits. Read more...

Prolia Dramatically Lowers Risk of Breaking Bones in Women Taking Aromatase Inhibitors
June 10, 2015
A study found that Prolia reduced the risk of breaking a bone by 50% in postmenopausal women diagnosed with early-stage, hormone-receptor-positive breast cancer who were taking an aromatase inhibitor. Read more...

Study Confirms Taxol Better Than Ixempra or Abraxane for Locally Advanced or Metastatic Disease
June 16, 2015
Taxol stops advanced-stage breast cancer from growing longer than Ixempra or Abraxane. Read more...

Study Suggests Link Between DDT Exposure in Womb and Higher Breast Cancer Risk
June 17, 2015
Research suggests that women exposed to higher levels of the pesticide DDT in the womb have a breast cancer risk 4 times higher than average. Read more...

Freezing Embryos Helps Women Conceive After Breast Cancer Treatment
June 24, 2015
A study suggests that a number of factors, including access to radiation therapy after lumpectomy, affect the type of surgery a woman chooses for early-stage breast cancer. Read more...

Partial-Breast Radiation Offers Survival, Recurrence Rates Similar to Whole-Breast Radiation After Lumpectomy
July 7, 2015
One of the largest studies done so far on the outcomes of brachytherapy suggests that brachytherapy after lumpectomy results in survival rates and recurrence rates that are similar to whole-breast radiation. Read more...

Women Who've Been Diagnosed With Breast Cancer More Likely to Gain Weight Than Women Who Haven't Been Diagnosed
July 16, 2015
Diagnosed women gained an average of about 4 pounds more than women who hadn't been diagnosed. Read more...

ASCO Issues Guidelines on Using Biomarkers to Make Treatment Decisions in Women Diagnosed With Metastatic Disease
July 22, 2015
The American Society of Clinical Oncology has issued new recommendations on using biomarkers to make metastatic breast cancer treatment decisions. Read more...

Exercising 300 Minutes Per Week Leads to More Fat Loss in Postmenopausal Women
July 24, 2015
Exercising twice the recommended amount -- for a total of 300 minutes per week -- is better for shedding fat, especially in postmenopausal women. Read more...

Does End-Stage Chemotherapy Improve Quality of Life?
July 28, 2015
A study suggests that few people benefit from end-of-life chemotherapy and many people have worse quality of life after receiving it. Read more...

Lidocaine May Help Ease Painful Intercourse After Breast Cancer Treatment
July 30, 2015
A small study has found that applying a lidocaine compress to the area where the vulva meets with the vagina can make intercourse comfortable again for women who've been treated for breast cancer. Read more...

Older and Heavier Women More Likely to Have Heart Problems When Treated With Anthracycline Chemotherapy
July 31, 2015
Older women and women with a higher body mass index are more likely to have anthracycline-related heart problems. Read more...

More Young Men Than Young Women Take Steps to Preserve Fertility Before Cancer Treatment
August 4, 2015
A study found that young men diagnosed with cancer were 4 to 5 times more likely to take steps to preserve fertility than young women diagnosed with cancer. Read more...

Shorter Radiation Regimen Causes Fewer Side Effects, Offers Better Quality of Life Than Traditional Regimen
August 12, 2015
Hypofractionated radiation after lumpectomy offers better quality of life than conventional schedule. Read more...